Last updated: 2026-09-05 16:35:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
IQVIA Holdings Inc. (IQV) operates in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector and is listed on NYSE. The stock is currently priced at $267.63, with a market capitalization of $44.71B and a P/E ratio of 32.05. Over the past 52 weeks, its price has ranged from $154.50 to $272.38. This page covers its latest market performance, valuation, price trends and company information.
$44.71B | |
$267.50 | |
$285.61 | |
$81.79 | |
$271.62 | |
934.26K | |
1.44M | |
32.05 | |
$272.38 | |
$154.50 | |
-- | |
-- |
IQVIA Holdings Inc. (IQV) last closed at $271.62 as of 2026-09-04 23:58:00, unchanged from the previous close of $271.62.
During the latest regular trading session, IQV traded between $81.79 and $285.61, with a volume of 934.26K shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, IQVIA Holdings Inc. (IQV) moved from $262.38 to $267.63, representing a gain of 2.00% ($5.25).
The stock traded between $256.02 and $272.38 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 1.42 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 96.0%
IQV is currently trading at $267.63, placing it 96.0% of the way from its 52-week low of $154.50 to its 52-week high of $272.38. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
| Industry | SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH |
| Employees | 94000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of IQVIA Holdings Inc. (IQV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.